ARTLVSGTBP• 3 Months (Normalized)
ARTL vs GTBP (Artelo Biosciences Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Jul 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
+%
Artelo Biosciences Inc.
Normalized Baseline0.00%
GTBP Performance $6.88
+1356.57%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-1356.57 pts
GTBP outperforming by 1356.57 percentage points
ARTLGTBP
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | ARTL Price | ARTL Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $6.88 | +1356.57% | - | |
| Sep 28, 2026 | $- | $6.80 | +1340.68% | - | |
| Sep 25, 2026 | $4.54 | -54.55% | $6.89 | +1359.75% | -1414.30% |
| Sep 24, 2026 | $5.17 | -48.25% | $6.83 | +1347.03% | -1395.28% |
| Sep 23, 2026 | $7.31 | -26.83% | $7.10 | +1404.24% | -1431.07% |
| Sep 22, 2026 | $4.15 | -58.46% | $- | - | |
| Sep 21, 2026 | $4.10 | -58.96% | $7.18 | +1421.19% | -1480.15% |
| Sep 18, 2026 | $3.94 | -60.56% | $7.16 | +1416.95% | -1477.51% |
| Sep 17, 2026 | $3.97 | -60.26% | $7.49 | +1486.86% | -1547.12% |
| Sep 16, 2026 | $3.75 | -62.46% | $7.81 | +1554.66% | -1617.12% |
| Sep 15, 2026 | $5.34 | -46.55% | $9.00 | +1806.78% | -1853.33% |
| Sep 14, 2026 | $4.87 | -51.25% | $11.63 | +2363.98% | -2415.23% |
| Sep 11, 2026 | $5.43 | -45.65% | $8.61 | +1724.15% | -1769.80% |
| Sep 10, 2026 | $5.63 | -43.64% | $6.18 | +1209.32% | -1252.96% |
| Sep 09, 2026 | $5.98 | -40.14% | $5.98 | +1166.95% | -1207.09% |
Page 1 of 5